zsp1273 granules

DRUG2 trials

Sponsors

Guangdong Raynovent Biotech Co., Ltd

Conditions

BioequivalenceInfluenza a

Phase 1

Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273

CompletedNCT06164431

Guangdong Raynovent Biotech Co., LtdBioequivalence

Start: 2023-11-23End: 2023-12-22Updated: 2024-01-29

Phase 2

Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A

CompletedNCT06656026

Guangdong Raynovent Biotech Co., LtdInfluenza a

Start: 2024-11-30End: 2025-07-31Updated: 2025-11-17